Cirrhosis as new indication for statins

Gut
Jaime BoschJuan G Abraldes

Abstract

In the recent years, there have been an increasing number of reports on favourable effects of statins in patients with advanced chronic liver disease. These include reduction in portal pressure, improved liver sinusoidal endothelial and hepatic microvascular dysfunction, decreased fibrogenesis, protection against ischaemia/reperfusion injury, safe prolongation of ex vivo liver graft preservation, reduced sensitivity to endotoxin-mediated liver damage, protection from acute-on-chronic liver failure, prevention of liver injury following hypovolaemic shock and preventing/delaying progression of cirrhosis of any aetiology. Moreover, statins have been shown to have potential beneficial effects in the progression of other liver diseases, such as chronic sclerosing cholangitis and in preventing hepatocellular carcinoma. Because of these many theoretically favourable effects, statins have evolved from being considered a risk to kind of wonder drugs for patients with chronic liver diseases. The present article reviews the current knowledge on the potential applications of statins in chronic liver diseases, from its mechanistic background to objective evidence from clinical studies.

References

Nov 1, 1993·American Journal of Hypertension·H T SmithW T Robinson
Mar 1, 2003·European Journal of Clinical Pharmacology·S G SimonsonM J Warwick
Aug 2, 2003·Gastroenterology·Manuel Morales-RuizWladimiro Jiménez
May 8, 2004·Gastroenterology·Naga ChalasaniStephen D Hall
Sep 1, 2004·JAMA : the Journal of the American Medical Association·James A de LemosUNKNOWN Investigators
Dec 13, 2005·Nature Reviews. Drug Discovery·Mukesh K Jain, Paul M Ridker
Dec 13, 2005·The Journal of Clinical Investigation·Kush M ParmarGuillermo García-Cardeña
Aug 31, 2006·Journal of Clinical Gastroenterology·Vamsee AllaHerbert L Bonkovsky
Jun 29, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jonel TrebickaJörg Heller
Aug 3, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·James H LewisUNKNOWN Pravastatin in Chronic Liver Disease Study Investigators
Jul 5, 2008·Clinical Reviews in Allergy & Immunology·Frank TackeChristian Trautwein
Jul 25, 2008·The New England Journal of Medicine·UNKNOWN SEARCH Collaborative GroupR Collins
Jul 28, 2009·The Journal of Surgical Research·Jan E SlottaHenrik Thorlacius
Mar 5, 2010·Neurology·H H FeldmanUNKNOWN LEADe Investigators
Jul 28, 2010·Journal of Gastroenterology and Hepatology·Hui-Chun HuangShou-Dong Lee
Aug 24, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Inge R H M KoningsStefan Sleijfer
Oct 21, 2010·American Journal of Respiratory and Critical Care Medicine·Peter S KrugerBala Venkatesh
Nov 3, 2010·Gastroenterology·Emmanuel A TsochatzisAndrew K Burroughs
Nov 12, 2010·Lancet·UNKNOWN Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative GroupRory Collins
Mar 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ji-Youn HanJin Soo Lee
Oct 28, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lucia RussoJaime Bosch
May 10, 2012·Journal of Neurology·Christian Philipp KammHeinrich Paul Mattle
Jul 26, 2012·Alcoholism, Clinical and Experimental Research·Dirk TheileSebastian Mueller
Sep 8, 2012·The Journal of Surgical Research·Aline Maria StolfAlexandra Acco
Nov 28, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Vincenzo La MuraJuan G Abraldes
Dec 13, 2012·Critical Care : the Official Journal of the Critical Care Forum·Jaimin M PatelFang Gao
Jan 26, 2013·American Journal of Respiratory and Critical Care Medicine·Peter KrugerUNKNOWN ANZ-STATInS Investigators–ANZICS Clinical Trials Group
Feb 23, 2013·Journal of Hepatology·Jordi Gracia-SanchoJaime Bosch
Mar 7, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Vijay R MoreAngela L Slitt
Mar 12, 2013·Gastroenterology·Richard MoreauUNKNOWN CANONIC Study Investigators of the EASL–CLIF Consortium
Jul 3, 2013·Journal of Hepatology·Carmen PeraltaJordi Gracia-Sancho

❮ Previous
Next ❯

Citations

Sep 15, 2020·Chinese Medical Journal·Jing-Hang XuXiao-Yuan Xu
Jan 1, 2021·Molecular Metabolism·Saswata Talukdar, Alexei Kharitonenkov
Feb 17, 2021·Nature Reviews. Gastroenterology & Hepatology·Jordi Gracia-SanchoRubén Francés
Nov 10, 2020·Hepatology Communications·Kelly L Hayward, Rianne A Weersink
Mar 26, 2021·Seminars in Liver Disease·Raquel Maeso-Díaz, Jordi Gracia-Sancho
Apr 12, 2021·Clinics in Liver Disease·Mattias Mandorfer, Benedikt Simbrunner
Apr 16, 2021·Expert Opinion on Emerging Drugs·Jonathan Andrew FallowfieldAndrew Robertson
Jul 20, 2021·The American Journal of Gastroenterology·Carlos Moctezuma-Velazquez, Juan G Abraldes
Sep 8, 2021·Frontiers in Nutrition·Yue YinXingshun Qi
Sep 21, 2021·Expert Opinion on Pharmacotherapy·Lucia BrodosiMaria Letizia Petroni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nature Reviews. Gastroenterology & Hepatology
Jaume Bosch, Xavier Forns
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Yue YuScott L Nyberg
Current Drug Targets
Roberto Giulio Romanelli, Cristina Stasi
© 2021 Meta ULC. All rights reserved